SPAC JATT II Prices $60 Million IPO, Targets Healthcare

IPO Details and Capital Raised

JATT II Acquisition Corp, a special purpose acquisition company (SPAC), has officially priced its initial public offering, raising $60 million. The company offered 6 million ordinary shares at a price of $10.00 per share.

Market Entry and Strategic Focus

As a newly formed blank check company, JATT II will list on the NASDAQ exchange under the ticker symbol "JATT" starting April 17, 2026. The company intends to focus its acquisition search on businesses within the healthcare and life sciences sectors, particularly those leveraging data-driven technologies like machine learning.

Offering Structure and Underwriter Options

Guggenheim Securities serves as the sole book-running manager for the transaction, which is scheduled to close on April 20, 2026. The offering provides underwriters a 45-day option to purchase up to 900,000 additional shares to cover over-allotments. The company has not yet identified a specific merger target.

Summary

The successful IPO provides JATT II Acquisition Corp with the capital to pursue a merger with a promising company in the high-growth, data-driven healthcare space. Market participants will now monitor the company's progress in identifying and executing a business combination.

FAQ

Q: What is the ticker symbol for JATT II Acquisition Corp?
A: The company will trade on NASDAQ under the ticker symbol "JATT".

Q: How much did JATT II Acquisition Corp raise in its IPO?
A: The company raised $60 million by offering 6 million shares at $10.00 per share.

Source: Investing.com